Inventiva (IVA) Short Interest Ratio & Short Volume → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free IVA Stock Alerts $3.63 +0.07 (+1.97%) (As of 12:19 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Inventiva Short Interest DataCurrent Short Volume68,400 sharesPrevious Short Volume77,700 sharesChange Vs. Previous Month-11.97%Dollar Volume Sold Short$216,144.00Short Interest Ratio / Days to Cover1.7Last Record DateApril 30, 2024Outstanding Shares52,480,000 sharesPercentage of Shares Shorted0.13%Today's Trading Volume3,569 sharesAverage Trading Volume31,852 sharesToday's Volume Vs. Average11% Short Selling Inventiva ? Sign up to receive the latest short interest report for Inventiva and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIVA Short Interest Over TimeIVA Days to Cover Over TimeIVA Percentage of Float Shorted Over Time Ad StarpaxInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpax’s technology is set to revolutionize cancer care and improve the lives of patients worldwide. Be part of a mission to create a world where cancer treatment is more effective, safe and accessible.Invest today Inventiva Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202468,400 shares $216,144.00 -12.0%N/A1.7 $3.16 4/15/202477,700 shares $254,856.00 +34.9%N/A2 $3.28 3/31/202457,600 shares $208,512.00 -52.8%N/A1.5 $3.62 3/15/2024121,900 shares $511,980.00 +14.5%N/A3.5 $4.20 2/29/2024106,500 shares $385,530.00 +20.8%N/A5.1 $3.62 2/15/202488,200 shares $351,036.00 -0.3%N/A5.2 $3.98 Get the Latest News and Ratings for IVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inventiva and its competitors with MarketBeat's FREE daily newsletter. 1/31/202488,500 shares $336,300.00 +8.3%N/A8.3 $3.80 1/15/202481,700 shares $361,931.00 +14.1%N/A8.2 $4.43 12/31/202371,600 shares $323,345.60 -12.2%N/A7.4 $4.52 12/15/202381,500 shares $339,040.00 -2.7%N/A9 $4.16 11/30/202383,800 shares $347,770.00 -6.6%N/A7.8 $4.15 11/15/202389,700 shares $349,830.00 -1.2%N/A6 $3.90 10/31/202390,800 shares $343,405.60 +14.7%N/A5.8 $3.78 10/15/202379,200 shares $316,800.00 +4.4%N/A4.2 $4.00 9/30/202375,900 shares $318,780.00 -16.5%N/A3.7 $4.20 9/15/202390,900 shares $336,330.00 -5.6%N/A3.6 $3.70 8/31/202396,300 shares $365,940.00 +12.6%N/A0.7 $3.80 8/15/202385,500 shares $307,800.00 -7.1%N/A0.6 $3.60 7/31/202392,000 shares $376,280.00 -18.1%N/A0.6 $4.09 7/15/2023112,300 shares $478,398.00 -18.7%N/A0.8 $4.26 6/30/2023138,200 shares $558,328.00 +22.5%N/A0.9 $4.04 6/15/2023112,800 shares $516,624.00 +48.6%N/A0.8 $4.58 5/31/202375,900 shares $299,425.50 +10.0%N/A2.2 $3.95 5/15/202369,000 shares $186,300.00 -64.6%N/A3.7 $2.70 4/30/2023194,800 shares $529,856.00 -8.0%N/A12 $2.72 4/15/2023211,700 shares $642,678.86 +6.5%N/A19.4 $3.04 3/31/2023198,700 shares $723,268.00 +7.9%N/A20.3 $3.64 3/15/2023184,100 shares $741,923.00 -6.1%N/A27.1 $4.03 2/28/2023196,000 shares $1.00 million -0.2%N/A35.6 $5.11 2/15/2023196,300 shares $1.21 million +2.2%N/A29.7 $6.15 1/31/2023192,100 shares $1.20 million -0.2%0.5%25.6 $6.22 1/15/2023192,500 shares $1.16 million -0.1%0.5%20.3 $6.05 12/30/2022192,700 shares $859,442.00 -0.8%0.5%3.9 $4.46 12/15/2022194,300 shares $790,801.00 +2.8%N/A3.8 $4.07 11/30/2022189,000 shares $789,075.00 +27.4%0.5%3.5 $4.18 11/15/2022148,300 shares $647,329.50 -7.9%0.4%2.8 $4.37 10/31/2022161,000 shares $737,380.00 +1.7%0.4%3.2 $4.58 10/15/2022158,300 shares $883,314.00 +10.8%0.4%3.2 $5.58 9/30/2022142,900 shares $562,039.99 +4.2%0.4%3.1 $3.93 9/15/2022137,100 shares $534,690.00 -0.4%0.4%18 $3.90Guard Against the Coming Financial Upheaval (Ad)America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.You can stream it for free right here. IVA Short Interest - Frequently Asked Questions What is Inventiva's current short interest? Short interest is the volume of Inventiva shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 68,400 shares of IVA short. Learn More on Inventiva's current short interest. What is a good short interest ratio for Inventiva? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IVA shares currently have a short interest ratio of 2.0. Learn More on Inventiva's short interest ratio. Is Inventiva's short interest increasing or decreasing? Inventiva saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 68,400 shares, a decrease of 12.0% from the previous total of 77,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Inventiva's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Inventiva: scPharmaceuticals Inc. (17.76%), Organigram Holdings Inc. (5.87%), Greenwich LifeSciences, Inc. (3.24%), Alimera Sciences, Inc. (0.23%), Capricor Therapeutics Inc (13.14%), Seres Therapeutics, Inc. (14.17%), Gossamer Bio, Inc. (5.68%), Acrivon Therapeutics, Inc. (5.22%), ProQR Therapeutics (0.41%), Lifecore Biomedical, Inc. (6.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Inventiva stock? Short selling IVA is an investing strategy that aims to generate trading profit from Inventiva as its price is falling. IVA shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Inventiva? A short squeeze for Inventiva occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IVA, which in turn drives the price of the stock up even further. How often is Inventiva's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IVA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: scPharmaceuticals Short Interest Data Organigram Short Interest Data Greenwich LifeSciences Short Interest Data Alimera Sciences Short Interest Data Capricor Therapeutics Short Interest Data Seres Therapeutics Short Interest Data Gossamer Bio Short Interest Data Acrivon Therapeutics Short Interest Data ProQR Therapeutics Short Interest Data Lifecore Biomedical Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IVA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals